Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Gentulizumab

Gentulizumab (Gensci-059) is a humanized IgG4 antibody that targets CD47. Gentulizumab displays strong binding to CD47 in both human and monkey, and effectively inhibits the CD47-SIRPα interaction. Gentulizumab exhibits a potent antitumor activity. The isotype control for Gentulizumab can refer to Human IgG4 (S228P) kappa, Isotype Control.

Product Specifications

Product Name Alternative

Gensci-059

UNSPSC

12352203

Target

CD47

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

97.02

Smiles

[Gentulizumab]

Molecular Weight

(145.97 kDa)

References & Citations

[1]Wang T, et al. Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile. J Transl Med. 2024 Mar 1;22 (1) :220.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 1

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Fluorescein-dT CPG
6205-AAT 100 mg

Fluorescein-dT CPG

Sign In for Pricing
View Details
(+)-19-Norandrost-4-ene-3,17-dione
TRC-N661000-1G 1 g

(+)-19-Norandrost-4-ene-3,17-dione

Sign In for Pricing
View Details
6,8-Dihydro-7H-pyrrolo[2,3-g]benzothiazol-7-one
TRC-D453658-50MG 50 mg

6,8-Dihydro-7H-pyrrolo[2,3-g]benzothiazol-7-one

Sign In for Pricing
View Details
Nsg2 (NM_008741) Mouse Tagged ORF Clone
MG201438 10 µg

Nsg2 (NM_008741) Mouse Tagged ORF Clone

Sign In for Pricing
View Details
Tissue Total RNA, Kidney
CR562811 5 µg

Tissue Total RNA, Kidney

Sign In for Pricing
View Details
TRIM29 (TRIM29/1042), 0.2mg/mL
BNUB1042-100 1x 100 µL

TRIM29 (TRIM29/1042), 0.2mg/mL

Sign In for Pricing
View Details